European Medicines Agency, Amsterdam, the Netherlands
Start date:
4 December 2024
End date:
6 December 2024
EventHumanAdvanced therapiesInnovation
European Medicines Agency, Amsterdam, the Netherlands
Start date:
3 December 2024
End date:
5 December 2024
EventVeterinaryMedicines
European Medicines Agency, Amsterdam, the Netherlands
Start date:
3 December 2024
End date:
5 December 2024
EventHumanRare diseases
EudraVigilance is the EU's system for managing and analysing information on adverse reactions to medicines which have been authorised or are being studied in clinical trials in the European Economic Area (EEA) and supports the reporting and analysis of suspected adverse reactions originating from clinical trials and the post-authorisation phase of...
Online
Start date:
2 December 2024
End date:
6 December 2024
EventHumanClinical trials
European Medicines Agency, Amsterdam, the Netherlands
Start date:
2 December 2024
End date:
2 December 2024
EventHumanResearch and development
European Medicines Agency, Amsterdam, the Netherlands
Start date:
29 November 2024
End date:
29 November 2024
EventCorporate
Online
European Medicines Agency, Amsterdam, the Netherlands
Live broadcast
Start date:
28 November 2024, 09:30 (CET)
End date:
28 November 2024, 17:30 (CET)
EventHumanMedicines
EudraVigilance is the EU's system for managing and analysing information on adverse reactions to medicines which have been authorised or are being studied in clinical trials in the European Economic Area (EEA) and supports the reporting and analysis of suspected adverse reactions originating from clinical trials and the post-authorisation phase of...
Online
Start date:
26 November 2024
End date:
28 November 2024
EventHumanClinical trials
Online
European Medicines Agency, Amsterdam, the Netherlands
Start date:
25 November 2024, 10:00 (CET)
End date:
25 November 2024, 11:30 (CET)
EventHumanMedicines
Online
European Medicines Agency, Amsterdam, the Netherlands
Start date:
25 November 2024, 09:00 (CET)
End date:
28 November 2024, 13:30 (CET)
EventHumanClinical trials